Contact Us
Drug Search Results
More Filters [+]

Benperidol

Alternative Names: benperidol
Latest Update: 2024-04-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: D2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Germany | India | Ireland | Luxembourg | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Hannover Medical School
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Benperidol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Schizophrenia|Affective Disorders, Psychotic|Psychotic Disorders

Phase 3: Depressive Disorder|Schizophrenia|Psychophysiologic Disorders|Dementia|Tic Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
GAP

P3

Terminated

Depressive Disorder|Dementia|Psychophysiologic Disorders|Tic Disorders|Schizophrenia

2017-06-28

DO 1723/1-1

P4

Completed

Affective Disorders, Psychotic|Schizophrenia|Psychotic Disorders

2016-06-22

2013-000338-37

P4

Completed

Schizophrenia

2016-06-22

APIC

P4

Terminated

Schizophrenia

None

Recent News Events

Date

Type

Title

04/01/2024

PubMed

 Identifying novel aryl hydrocarbon receptor (AhR) modulators from clinically approved drugs: In silico screening and In vitro validation.

04/21/2022

PubMed

 The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer's Disease.

07/16/2021

PubMed

 Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed Workers.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions